Medindia » Press Release » Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting

Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting

  •   Print
  •   Share
  •   Comments
  •  Text 

QNEXA Treatment Over Two Years Leads to Significant Improvements in Prediabetic and Diabetic Patients

VIVUS, Inc.

Investor Relations:

The Trout Group

Timothy E. Morris

Brian Korb

Chief Financial Officer

bkorb@troutgroup.com

650-934-5200

646-378-2923

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments  
 
Comment & Contribute
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions   

  • Press Release Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Press Release Archive
Date :
Category :
Keyword :